Low hemagglutinin antigen dose influenza vaccines adjuvanted with AS03 alter the long-term immune responses in BALB/c mice
We investigated the long-term immune profiles of dose-sparing, AS03-adjuvanted vaccines compared to a traditional high-dose, unadjuvated influenza vaccine formulation. BALB/c mice received 2 IM injections of influenza A/Uruguay/716/2007 (H3N2) split vaccine antigen: high-dose (HD) (3 µg hemagglutini...
Saved in:
Main Authors: | Karen K. Yam (Author), Angela Brewer (Author), Virginie Bleau (Author), Édith Beaulieu (Author), Corey P. Mallett (Author), Brian J. Ward (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2017-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
220 mutation in the hemagglutinin of avian influenza A (H7N9) virus alters antigenicity during vaccine strain development
by: Liqi Liu, et al.
Published: (2018) -
The generation of hemagglutinin monoclonal antibodies against H9N2 influenza virus
by: Yongcheng Duan, et al.
Published: (2023) -
Single immunization with an influenza hemagglutinin nanoparticle‐based vaccine elicits durable protective immunity
by: Shiho Chiba, et al.
Published: (2024) -
Effect of [6]-gingerol on viral neuraminidase and hemagglutinin-specific T cell immunity in severe influenza
by: Avijit Dutta, et al.
Published: (2023) -
Co-Delivery of a Novel Lipidated TLR7/8 Agonist and Hemagglutinin-Based Influenza Antigen Using Silica Nanoparticles Promotes Enhanced Immune Responses
by: Walid M. Abdelwahab, et al.
Published: (2024)